Stock screener

CUE

Conviction 35HealthcareScan · Mon, Aug 10, 2026
CUE$26.03-4.02%
ResistanceSupportVol 14Insider buy
63 bars
2
Vol MA14 181.43K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Cue Biopharma, Inc.PHARMACEUTICAL PREPARATIONSwww.cuebiopharma.com
Price26.03
Change-4.02%
Gap+0.11%
Rel volume1.21×
Avg volume171.54K
Avg $ vol5.02M
SMA 2029.54
SMA 5029.08
SMA 20010.44
Price vs 50-10.49%
Price vs 200+149.27%
MA stackmixed
50/200 cross
Supertrenddown · 35.29
RSI (14)42
MACD hist-0.66
MACD cross
Stoch %K / %D11 / 15
ADX (14)19
+DI / −DI19 / 22
RSI divergence
MACD divergence
ATR %+12.51%
ADR %10.27%
52w high36.78
52w low0.1770
From 52w high-29.23%
Above 52w low+14606.21%
New 52w highNo
SqueezeOff
Bollinger width35.42%
%B0.16
Donchian pos10.63%
Donchian high35.57
Donchian low24.90
AVWAP (52w high)30.30
vs AVWAP high-14.09%
AVWAP (52w low)2.30
vs AVWAP low+1031.74%
OBV trendFlat
Chaikin MF (20)-0.18
Today vs 20d1.21×
Avg vol (14d)181.43K
Avg vol (20d)171.54K
Avg $ vol (20d)5.02M
Market cap105.31M
RS 3m (vs SPY)-29.79%
RS 6m (vs SPY)+8465.45%
RS line new highNo
Trend template5/8
Technical rank64.3
1 week-3.13%
1 month-29.23%
3 months-25.63%
6 months+8031.83%
1 year+3113.58%
YTD+7614.88%
P/E-3.96
P/B4.87
P/S3.83
P/FCF-4.82
EPS-0.2800
Div yield
ROE-123.11%
ROA-86.15%
Debt/Eq0.19
Current3.57
EV/EBITDA-3.63
Gross margin
Net margin-96.85%
Rev growth195.75%
EPS growth34.60%
Price target
Target upside
Analyst rating
Institutional16.18%
Ent. value92.93M
Revenue5.69M
Net income-5.18M
Gross profit
Free cash flow-21.86M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out4.2M
Employees29
ListedTue, Jan 2, 2018
Free float94.71M
Float %97.2%
Short interest307.89K
Days to cover2.2d
Short volume27.5%
Squeeze score15 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction35 / 100
Pattern quality
Tech rank64.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance40.54
Support23.88
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CUE

All disclosures →
No recent disclosed trades by Congress in CUE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CUE · 10 buys

InsiderSideShares
Borie Dominique Christian
Chief Medical Officer · Common Stock · 2026-07-13
Grant31.5K
Borie Dominique Christian
Chief Medical Officer · Stock Option (Right to Buy) · 2026-07-13
Grant63K
Camardo Daniel A.
Director · Common Stock · 2026-07-09
Grant21.8K
Ray Sumita
Chief Legal Compliance Officer · Common Stock · 2026-07-09
Grant54.59K
Ray Sumita
Chief Legal Compliance Officer · Common Stock · 2026-07-09
Grant54.59K
Lin Shao-Lee
Chief Executive Officer · Common Stock · 2026-07-09
Grant327.54K
Lin Shao-Lee
Chief Executive Officer · Common Stock · 2026-07-09
Grant327.54K
Garzone Pamela
Director · Common Stock · 2026-07-09
Grant21.8K
Sarraf Pasha
Director · Common Stock · 2026-07-09
Grant21.8K
Meehan Viola Mong
Director · Common Stock · 2026-07-09
Grant21.8K

SEC filings

EDGAR filings in CUE · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.